Quality Control and Selection Considerations for Biological Reagent Kits in In Vitro Diagnostics

Common Classifications and Application Scenarios

Biological reagent kits generally refer to the combined packaging of reagents, buffers, standards, or controls required for specific biological reactions, allowing laboratories or clinical institutions to complete testing according to a unified workflow. Based on detection principles, common types include immunoassay kits, molecular diagnostic kits, biochemical assay kits, and cell function analysis kits. Immunoassay kits are mostly used for antigen-antibody reactions, such as enzyme-linked immunosorbent assay; molecular diagnostic kits are commonly used for nucleic acid extraction, amplification, and signal readout. Different application scenarios have different performance requirements for kits. Clinical testing places greater emphasis on result stability and reproducibility, while research experiments also need to consider sample type compatibility.

In the field of in vitro diagnostics, the value of biological reagent kits lies in reducing manual preparation steps and minimizing batch-to-batch variation. Generally, kit components are required to have clear labeling, explicit instructions, and specified applicable sample types, storage conditions, and post-opening shelf life. Users should select the appropriate methodology based on their own testing objectives, rather than merely looking at similar names.

Quality Control and Performance Evaluation

Quality control is a core link in the use chain of biological reagent kits. Laboratories typically monitor whether each run is within the normal range through blank controls, negative controls, and positive controls. For quantitative detection, attention should also be paid to indicators such as standard curve linearity, limit of detection, and precision. Kits are generally required to undergo strict quality inspection before leaving the factory, but temperature fluctuations during transport and storage may affect activity. Therefore, upon arrival, the packaging integrity, storage temperature records, and shelf life should first be verified.

Check the kit appearance and component list to avoid leakage or illegible labels.

Confirm that storage temperature meets the instructions, such as whether cold chain transport was maintained.

Establish rules for the use of internal quality control materials and record batch changes.

Test new batches in parallel with old batches to observe result shifts.

For clinical testing purposes, attention should also be paid to whether the kit has completed filing or registration in accordance with relevant medical device regulations, and whether the product label contains registration certificate numbers or filing credential information. This helps identify product compliance status and avoid using products of unknown origin.

Common Precautions in Storage and Operation

Components such as enzymes, antibodies, primers, or substrates in biological reagent kits are relatively sensitive to temperature, humidity, and light. It is generally recommended to store them at 2 to 8 degrees Celsius or lower according to the instructions. Some lyophilized components may be transported at room temperature for short periods, but long-term preservation is still best at low temperature. Repeated freeze-thaw cycles may cause protein or nucleic acid degradation. Therefore, after opening, aliquoting according to single-use amounts can reduce unnecessary repeated handling.

Operational steps also affect results. Pipetting accuracy, reaction time, washing adequacy, and light protection requirements may all cause systematic bias. Kits of common specifications usually provide sufficient reagent volume to complete the specified number of tests, but improper operation may lead to insufficient reagent or cross-contamination. Before use, the warnings and precautions in the instructions should be read, especially those involving biosafety or chemical safety.

Selection and Collaboration Evaluation

When facing various biological reagent kits on the market, price should not be the sole basis for judgment. A comprehensive evaluation can generally be made from dimensions such as manufacturer qualifications, product filing or registration status, batch stability, technical support capability, and supply continuity. For research users, literature citations and user feedback can be considered; for clinical users, it is necessary to verify whether the applicable scope covers the testing items conducted by their institution.

Standardized use and management of biological reagent kits help improve the credibility of test results and reduce internal quality risks in laboratories. With increasing automation and informatization, traceability information and electronic instructions for kits will also become more widespread, but the core still lies in users' understanding of methodological principles and quality control logic.

Digitalization and Traceability Trends

With the advancement of digital laboratory management, some biological reagent kits have begun to include QR codes or electronic data packages, making it convenient for users to query batch instructions, quality control data, and shelf life reminders. For clinical institutions, storing kit compliance information in association with test results helps meet quality system audit requirements. For research laboratories, electronic records can also reduce the burden of manual registration and improve experimental reproducibility.